Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Retina Vitreous Associates of Florida
ClinicalTrials.gov Identifier:
NCT01476449
First received: November 13, 2011
Last updated: October 3, 2016
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2016
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)